Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study

BACKGROUND: BBV152 is a whole-virion inactivated SARS-CoV-2 vaccine that has been deployed in India. The results of the phase 3 trial have shown clinical efficacy of BBV152. We aimed to evaluate the effectiveness of BBV152 against symptomatic RT-PCR-confirmed SARS-CoV-2 infection. METHODS: We conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Devashish, Khan, Adil Rashid, Soneja, Manish, Mittal, Ankit, Naik, Shivdas, Kodan, Parul, Mandal, Ayan, Maher, Ganesh Tarachand, Kumar, Rohit, Agarwal, Ayush, Gowda, Naveen R, H, Vikas, Kumar, Parmeshwar, Pandey, Shivam, Pandey, R M, Kumar, Arvind, Ray, Animesh, Jorwal, Pankaj, Nischal, Neeraj, Choudhary, Aashish, Brijwal, Megha, Madan, Karan, Lodha, Rakesh, Sinha, Sanjeev, Dar, Lalit, Wig, Naveet, Guleria, Randeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610201/
https://www.ncbi.nlm.nih.gov/pubmed/34826383
http://dx.doi.org/10.1016/S1473-3099(21)00674-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610201/
https://www.ncbi.nlm.nih.gov/pubmed/34826383
http://dx.doi.org/10.1016/S1473-3099(21)00674-5

Ejemplares similares